Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kawano, H.
Right arrow Articles by Nakagawa, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kawano, H.
Right arrow Articles by Nakagawa, M.
Related Collections
Right arrow Hemostasis, Thrombosis, and Vascular Biology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 15 March 2001, Vol. 97, No. 6, pp. 1697-1702

HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY

Serotonin induces the expression of tissue factor and plasminogen activator inhibitor-1 in cultured rat aortic endothelial cells

Hidehiko Kawano, Hajime Tsuji, Hiromi Nishimura, Shinzo Kimura, Shingo Yano, Naoki Ukimura, Yasufumi Kunieda, Masami Yoshizumi, Tatsuya Sugano, Katsumi Nakagawa, Haruchika Masuda, Shohei Sawada, and Masao Nakagawa

From the Second Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Serotonin (5-hydroxytryptamine, or 5-HT), released from activated platelets, not only accelerates aggregation of platelets but also is known to promote mitosis, migration, and contraction of vascular smooth muscle cells (VSMCs). These effects are considered to contribute to thrombus formation and atherosclerosis. The aim of this study was to investigate the effects of 5-HT on the expressions of coagulative and fibrinolytic factors in rat aortic endothelial cells. Endothelial cells were stimulated with various concentrations of 5-HT (0.1~10 µM), and the expressions of tissue factor (TF), tissue factor pathway inhibitor (TFPI), plasminogen activator inhibitor-1 (PAI-1), and tissue-type plasminogen activator (TPA) messenger RNAs (mRNAs) were evaluated by Northern blot analysis. The activities of TF and PAI-1 were also measured. TF and PAI-1 mRNA were increased significantly in a concentration- and time-dependent manner. However, TFPI and TPA mRNA expression did not change. The inductions of TF and PAI-1 mRNAs were inhibited by a 5-HT1/5-HT2 receptor antagonist (methiothepin) and a selective 5-HT2A receptor antagonist (MCI-9042). These results indicate that 5-HT increases procoagulant activity and reduces fibrinolytic activities of endothelial cells through the 5-HT2A receptor. It was concluded that the modulation of procoagulant and hypofibrinolytic activities of endothelial cells by 5-HT synergistically promotes thrombus formation at the site of vessel injury with the platelet aggregation, VSMC contraction, and VSMC proliferation.

© 2001 by The American Society of Hematology.
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Eur Respir JHome page
A. Fabre, J. Marchal-Somme, S. Marchand-Adam, C. Quesnel, R. Borie, M. Dehoux, C. Ruffie, J. Callebert, J-M. Launay, D. Henin, et al.
Modulation of bleomycin-induced lung fibrosis by serotonin receptor antagonists in mice
Eur. Respir. J., August 1, 2008; 32(2): 426 - 436.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. E. Linder, W. Ni, J. L. Diaz, T. Szasz, R. Burnett, and S. W. Watts
Serotonin (5-HT) in Veins: Not All in Vain
J. Pharmacol. Exp. Ther., November 1, 2007; 323(2): 415 - 421.
[Abstract] [Full Text] [PDF]


Home page
J Clin PharmacolHome page
N. Kotzailias, T. Andonovski, A. Dukic, V. L. Serebruany, and B. Jilma
Antiplatelet Activity During Coadministration of the Selective Serotonin Reuptake Inhibitor Paroxetine and Aspirin in Male Smokers: A Randomized, Placebo-Controlled, Double-blind Trial.
J. Clin. Pharmacol., April 1, 2006; 46(4): 468 - 475.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Steffel, T. F. Luscher, and F. C. Tanner
Tissue Factor in Cardiovascular Diseases: Molecular Mechanisms and Clinical Implications
Circulation, February 7, 2006; 113(5): 722 - 731.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Steffel, A. Akhmedov, H. Greutert, T. F. Luscher, and F. C. Tanner
Histamine Induces Tissue Factor Expression: Implications for Acute Coronary Syndromes
Circulation, July 19, 2005; 112(3): 341 - 349.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A. Slominski, J. Wortsman, and D. J. Tobin
The cutaneous serotoninergic/melatoninergic system: securing a place under the sun
FASEB J, February 1, 2005; 19(2): 176 - 194.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. Hironaka, M. Hongo, A. Sakai, E. Mawatari, F. Terasawa, N. Okumura, A. Yamazaki, Y. Ushiyama, Y. Yazaki, and O. Kinoshita
Serotonin receptor antagonist inhibits monocrotaline-induced pulmonary hypertension and prolongs survival in rats
Cardiovasc Res, December 1, 2003; 60(3): 692 - 699.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2001 by American Society of Hematology         Online ISSN: 1528-0020